Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 245-251

  Pilotto, Alberto ^a   Leandro, Gioacchino ^b   Franceschi, Marilisa ^a   Bierti, Luigi ^f   Di Battista, Roberto ^f   Notarbartolo, Alberto ^f   Pisciotta, Giuseppe ^f   Grassi, Andrea ^c   Crestani, Bruno ^c   Tafner, Giovanni ^d   Michelagnoli, Silvia ^e   Garotta, Fabrizio ^e  

^a SAN BORTOLO HOSPITAL   (Italy)

^b IRCCS   (Italy)

^c GENERAL HOSPITAL   (Italy)

^d IRCCS SAN CAMILLO HOSPITAL   (Italy)

^e PFIZER INC   (United States)

^f Ospedale S Bortolo ^*

Author keywords

Amoxycillin; Duodenal ulcer; Helicobacter pylori; Metronidazole; Pantoprazole

Indexed keywords

AMOXICILLIN; CARBON 13; METRONIDAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; UREA; UREASE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; ENDOSCOPY; EPIGASTRIC PAIN; ERADICATION THERAPY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL ANALYSIS; STOMACH ANTRUM; STOMACH BIOPSY; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES; SULFOXIDES; TREATMENT OUTCOME;

EID: 0033042385     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 1 Malfertheiner P, O'Morain C, Michetti P: The Maastricht Guidelines and other innovations. Curr Op Gastroenterol 1997; 13(Suppl 1):1-7.
2. 2 Bazzoli F, Zagari RM, Fossi S, et al: Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6:773-777.
3. 3 Jaup BH, Norrby A; Low-dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90:943-945.
4. 4 Labenz J, Stolte M, Ruhl GH, Becker T, Tillenburg B, Sollbohmer M, Borsch G: One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7:9-11.
5. 5 Soll AH for the Practice Parameters Committee of the American College of Gastroenterology: Medical treatment of peptic ulcer disease. JAMA 1996; 275:622-629.
6. 6 The European Helicobacter pylori Study Group: Current European concepts in the management of Helicobacter pylori infection. The Máastricht Consensus Report. Gut 1997; 41:8-13.
7. 7 Fitton A, Wiseman L: Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 51:460-482.
8. 8 Misiewicz JJ, Tytgat GNJ, Goodwin CS, Price AB, Sipponen P, Strickland RG, Cheli R: The Sydney System: a new classification of gastritis. Working Party Reports of the 9th World Congress of Gastroenterology. Blackwell Scientific, Melbourne, 1990; pp. 1-10.
9. 13C urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3:915-921.
10. 10 Atherton JC: Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Alim Pharmacol Ther 1997; 11(Suppl 1):11-20.
11. 11 Dammann HG, Folsch UR, Hahn EG, Kleist DH, Klor HU, Kirchner T, Kist M: 7 vs. 14 day treatment with pantoprazole, clarithromycin and metronidazole for cure of H. pylori infection in duodenal ulcer patients. Gut 1997; 41(Suppl 1):A-95.
12. 12 Glasbrenner B, Ellenrieder V, Fensterer H, Waurick M, Adloer G: One-week treatment of Helicobacter pylori infection with pantoprazole, metronidazole and clarithromycin. Gut 1997; 41(Suppl 3):A-51.
13. 13 Adamek RJ, Bethke T: Pantoprazole, clarithromycin and metronidazole vs. pantoprazole and clarithromycin for cure of H. pylori infection in duodenal ulcer patients. Gastroenterol 1996; 110:A-48.
14. 14 Frevel M, Daake H, Janisch HD, Kellner HU, Krezdom H, Tanneberger D, Wack R, Gatz G: Pantoprazole plus clarithromycin and metronidazole versus pantoprazole plus clarithromycin and amoxycillin for therapy of H. pylori infection. Gut 1997; 41(Suppl 1):A-103.
15. 15 Rodriguez Tellez M, Valenzuela M, Martin Ruiz JL, Carmona I, Quintero MD, Lavin I: Effect of clarithromycin, amoxycillin and pantoprazole in duodenal ulcer healing and H. pylori eradication. Preliminary report. Gut 1997; 41(Suppl 3):A-208.
16. 16 Labenz J, Tillemburg B, Weismuller J, Lutke A, Stolte M: Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. Alim Pharmacol Ther 1997; 11:95-100.
17. 17 Glaser J, Heim J, Daikeler R, Weithofer G, Vieth M, Schmidt M, Stolte M: Kurzzeit-Tripeltherapie mit pantoprazol, amoxicillin und melronidazol bei Helicobacter-pylori-infektion. Med Klin 1998; 93:65-69.
18. 18 Lamouliatte H, The Aquitaine-Gastro Association, de Mascarel A, Megraud F, Samoyeau R: Double-blind study comparing once daily versus twice daily dosage of PPI with amoxycillin-clarithromycin for H. pylori cure. Gut 1997; 41(Suppl 1):A-93.
19. 19 Cederbrant G, Kahlmeter G, Schalen C, Kamme C: Additive effect of clarithromycin with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J Antimicrob Chemoter 1994; 34:1025-1029.
20. 20 Megraud F: Resistance of Helicobacter pylori to antibiotics. Alim Pharmacol Ther 1997; 11(Suppl 1):43-53.
21. 21 Tucci A, Varoli O, Corinaldesi R, Stanghellini V, Gasperoni S, Paparo GF, Ricci-Maccarini M, La Placa M, Barbara L: Evaluation of Helicobacter pylori sensitivity to amoxycillin and metronidazole in dyspeptic patients. Ital J Gastroenterol 1993; 25:65-67.
22. 22 Pilotto A, Rassu M, Franceschi M, Furlan F, D' Allotta P, Scagnelli M, Valerio G: Susceptibility of Helicobacter pylori to different antibiotics and effects of the resistances on eradication rates. Ital J Gastroenterol & Hepatol 1997; 29(Suppl 2):A-60.
23. 23 Hartmann M, Theiss U, Huber R, Luhmann R, Bliesath H, Wurst W, Lucker PW: Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Alim Pharmacol Ther 1996; 10:359-366.
24. 24 Bardhan KD, Bianchi Porro G, Buse K, Daly M, Hinkliffe G, Jonsson E, Lazzaroni M, Niesdal A, Rikner L, Walan A: A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986; 8:408-413.
25. 25 Hawkey CJ, Long KG, Bardhan KD, Wormsley KG, Cochran KM, Christian J, Moules IK: Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut 1993; 34:1458-1462.